WHO Prequalifies Arthritis Drug Tocilizumab for Severe Covid Cases
[ad_1] The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe Covid-19, in a bid to increase access to the pricey drug. The monoclonal antibody, used in anti-inflammatory drugs made by Swiss pharma giant Roche, has been shown to reduce the risk of death […]
WHO Prequalifies Arthritis Drug Tocilizumab for Severe Covid Cases Read More »




